Navigation Links
Abbott Presents Long-Term Data From Extension Study Showing Adult Crohn's Patients Treated With HUMIRA(R) (Adalimumab) Maintained Remission
Date:5/21/2008

Three of Four HUMIRA Patients from CHARM Study in Remission at One Year

Maintained Remission at Two Years

ABBOTT PARK, Ill., May 21 /PRNewswire-FirstCall/ -- Results from an open-label extension study of two Abbott pivotal studies, CHARM and GAIN, demonstrate that adult moderate-to-severe Crohn's patients treated with HUMIRA(R) (adalimumab) achieved long-term clinical remission and clinical response, respectively, according to data presentations today at Digestive Disease Week(R) (DDW) in San Diego. DDW is the largest international gathering of physicians, researchers and academics in the fields of gastroenterology, hepatology, endoscopy and gastrointestinal surgery. Patients from CHARM and GAIN were followed through into a non-placebo controlled, ongoing open-label extension (OLE) trial. Patients from CHARM were followed a total of two years, and patients from the 4-week GAIN study were followed a total of one year.

The CHARM extension data demonstrated that three out of four patients (77 percent) taking HUMIRA, who were in remission at the end of the one-year pivotal study, maintained clinical remission for an additional year. The GAIN data showed that, of patients with a clinical response at four weeks, approximately 65 percent remained in clinical response at one year, and 40 percent were in clinical remission at one year. Response was measured by change in Crohn's Disease Activity Index (CDAI), a weighted composite score of eight clinical factors that evaluate patient wellness, including daily number of liquid or very soft stools, severity of abdominal pain, levels of general well-being and other measures. Clinical remission was measured as a score of less than 150 and clinical response was measured as a decline of at least 70 points from baseline.

Crohn's disease is a serious, chronic, inflammatory bowel disease that affects more than 500,000 Americans. It affects people of all ages but it is primarily a disease
'/>"/>

SOURCE Abbott
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. XIENCE(TM) V Drug Eluting Stent from Abbott Outperforms Market-Leading Stent in Reducing Major Adverse Cardiac Events at Two Years
2. Study in JAMA Shows Patients Treated With Abbotts XIENCE(TM) V Drug Eluting Stent Experience Better Outcomes Than Patients Treated With Market-Leading Drug Eluting Stent
3. Abbotts Phase III Studies of Investigational TriLipix(TM) (ABT-335), in Combination With Statins, Meets Primary Endpoints on Improving LDL, Triglycerides and HDL
4. Abbotts XIENCE(TM) V Drug Eluting Stent Demonstrates Consistent and Positive Clinical Outcomes Out to Two Years
5. Abbotts HUMIRA(R) (adalimumab) Receives FDA Approval For Moderate to Severe Chronic Plaque Psoriasis
6. Abbotts m2000(TM) Molecular Diagnostic Instrument and RealTime HIV-1 Test Win Chicago Innovation Award
7. Abbott Announces Positive One-Year Results from the Worlds First Clinical Trial of a Fully Bioabsorbable Drug Eluting Coronary Stent
8. Abbotts XIENCE(TM) V Everolimus Eluting Coronary Stent Shows Continued Superiority to TAXUS Stent in Reducing Major Adverse Cardiac Events in SPIRIT III Clinical Trial
9. Abbotts ABT-874 Shows Positive Results for Maintenance of Response in Phase II Psoriasis Study
10. Abbott Initiates Clinical Study to Evaluate Use of RX Herculink(R) Elite(TM) Renal Stent System for the Treatment of Renal Artery Stenosis
11. Abbott and AstraZeneca Announce Selection of Next-Generation Fenofibrate ABT-335 and CRESTOR(R) Fixed-Dose Combination
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/16/2013)... 16, 2013  Alere Inc. (NYSE: ALR ), ... their health at home through the merger of rapid diagnostics ... per share on its Series B Convertible Perpetual Preferred Stock ... to holders of record of Series B stock at the ... payment will cover the amount of all dividends accrued from ...
(Date:5/16/2013)... , May 16, 2013 OrthoView ... the U.S. to access the widely-used OrthoView digital templating ... and Internet connection to get started. OrthoView, ... for over 10 years, is dedicated to enabling orthopaedic ... digital x-ray images, when printed film is unavailable. Over ...
(Date:5/16/2013)... FLORHAM PARK, N.J. , May 16, 2013 /PRNewswire/ ... reveals that women living with vulvar and vaginal atrophy ... and chronic condition, or are simply dissatisfied with the ... al Women ,s VI ews of Treatment ... exposed multiple barriers to the treatment of VVA, including ...
Breaking Medicine Technology:OrthoView Announces the U.S. Launch of a New, Subscription-based, Digital Planning and Templating Solution for Individual Orthopaedic Surgeons 2New Survey Results from 3,000 Postmenopausal Women Living with Vulvar and Vaginal Atrophy 2New Survey Results from 3,000 Postmenopausal Women Living with Vulvar and Vaginal Atrophy 3
... NEW YORK, Nov. 17, 2010 ACCESS ... a biopharmaceutical company leveraging its proprietary drug-delivery platforms ... care and diabetes, announced that two oncology posters are ... Prevention and Research Conference at the Austin Convention Center ...
... Corporation (Nasdaq: LMNX ), today announced that ... xTAG® CYP2D6 Kit, which recently received 510(k) clearance from ... test enables a personalized medicine approach to help physicians ... that are metabolized by the enzyme cytochrome P450 2D6. ...
Cached Medicine Technology:Access Pharmaceuticals ProLindac™ and CobaCyte™ Oncology Research Displayed at the Innovations in Cancer Prevention and Research Conference, November 17-19, 2010 2Access Pharmaceuticals ProLindac™ and CobaCyte™ Oncology Research Displayed at the Innovations in Cancer Prevention and Research Conference, November 17-19, 2010 3Luminex Corporation Launches New FDA Cleared Pharmacogenetic Diagnostic Test 2Luminex Corporation Launches New FDA Cleared Pharmacogenetic Diagnostic Test 3
(Date:5/18/2013)... Wine World Accessories, a renowned online store ... attractive 25% discount on Franmara Dynamo Electric Wine ... purchase this electric corkscrew opener for $44.95 via Wine ... online store ensures delivery of their items within 1-2 ... , A spokesperson from the online store elaborates the ...
(Date:5/18/2013)... CA (PRWEB) May 18, 2013 ... latest update to consumers about transvaginal mesh ... federal court Resource4thePeople reports that plaintiffs have ... to court documents. , The rulings came ... District Court in the Southern District of ...
(Date:5/18/2013)... (PRWEB) May 18, 2013 Medical device company, ... for its much anticipated mobility aid with its namesake, the ... a hands-free crutch alternative that injured individuals can ... ankle, for example, can remain active and walk during a ... using its reservation system to ensure those who need the ...
(Date:5/18/2013)... 2013 Three new locations will be ... wellness centers and one therapeutic dispensary. Patient Appreciation Fair ... weekend of May 25th – May 27th, particularly honoring ... All events will take place from 11:00 ... Elements Therapeutic Dispensary , 10580 S. State Route 69, ...
(Date:5/17/2013)... inflict lasting damage to brain regions associated with fear ... stress disorder, or PTSD, have shown that these brain ... such as recalling a traumatic event or reacting to ... NYU School of Medicine have explored for the first ... with PTSD in the absence of external triggers. ...
Breaking Medicine News(10 mins):Health News:Now Save 25% on Franmara Dynamo Electric Wine Bottle Opener at Wine World Accessories 2Health News:2013 Alleged Transvaginal Mesh Complications Lawsuits Update: Resource4thePeople Reports Defendants Ordered to Provide Testimony, Documents 2Health News:2013 Alleged Transvaginal Mesh Complications Lawsuits Update: Resource4thePeople Reports Defendants Ordered to Provide Testimony, Documents 3Health News:2013 Alleged Transvaginal Mesh Complications Lawsuits Update: Resource4thePeople Reports Defendants Ordered to Provide Testimony, Documents 4Health News:FlexLeg Begins Offering New Mobility Aid 2Health News:Elements Honors Medical Marijuana Patients at Elements Health and Wellness Centers and Elements Therapeutic Dispensary 2Health News:Elements Honors Medical Marijuana Patients at Elements Health and Wellness Centers and Elements Therapeutic Dispensary 3Health News:Elements Honors Medical Marijuana Patients at Elements Health and Wellness Centers and Elements Therapeutic Dispensary 4Health News:For combat veterans suffering from post-traumatic stress disorder, 'fear circuitry' in the brain never rests 2
... of Facial Plastic Surgery, an innovative technique in African American rhinoplasty ... ... New York, NY (PRWEB) July 18, 2008 -- In a ... and Director of The Aesthetic Facial Surgery Institute of New ...
... intensive care can expect long-term quality of life at ... today in BioMed Central,s open access journal Critical ... allocation of resources to the treatment of heart attack ... other intensive care patient groups. , More than 600,000 ...
... for Healthcare Information Technology (CCHIT®) today announced that ... meets the Commission's ambulatory electronic health record (EHR) ... the CCHIT Certified seal, physicians and other providers ... product, allowing them to focus their evaluation on ...
... Universal,Health Services, Inc. (NYSE: UHS ) announced ... cash dividend of $0.08 per share on September 15,2008 ... Universal Health Services, Inc. is one of the ... and behavioral,health hospitals, and ambulatory centers nationwide and in ...
... reveal a lot about how they make decisions when feeling ... Associate Professor Uwe Dulleck, from the QUT Business Faculty, said ... it was, in fact, a natural reaction that had been ... the Australian arm of a study that was awarded an ...
... age 17 boosted odds for being heavy smoker , , THURSDAY, ... variations that affect their nicotine receptors seem to be at ... smoking before they turn 17, a new study says. ... young age are more likely to face severe nicotine dependence ...
Cached Medicine News:Health News:New Study Shows Facial Plastic Surgery Helps African American's Perserve Ethnicity 2Health News:New Study Shows Facial Plastic Surgery Helps African American's Perserve Ethnicity 3Health News:Heart attack not a death sentence 2Health News:gloEMR Version 4.0, gloStream's Flagship Electronic Medical Record Solution, Receives 2007 CCHIT Certification 2Health News:gloEMR Version 4.0, gloStream's Flagship Electronic Medical Record Solution, Receives 2007 CCHIT Certification 3Health News:Decisions under pressure: it's all in the heartbeat 2Health News:Gene Mutation Puts Some Kids at Risk for Tobacco Addiction 2
... The mobile universal operating table for ... top allows for unlimited C-arm access. ... for both neurosurgical and cardiovascular procedures. ... for floor support can easily be ...
... the Cmax operating table that combines all ... table with the radiolucence and precise mobility ... most advanced, versatile surgical table on the ... support advancements in surgical procedures and imaging ...
... Table offers complete imaging access, with nearly ... and mobile imaging C-Arms can pan from ... reposition the patient. Anesthesiologists will appreciate this ... drive, quality construction, and ease of operation. ...
...
Medicine Products: